Research Peptides · Cat. 062-10
Thyrotropin-Releasing Hormone (TRH) (Human, Rat, Mouse)
Supplied as 25 mg per unit. Purity ≥ 95%. Molecular weight 362.39. Species: Human, Mouse, Rat. Technical values shown are imported catalog fields and should be confirmed against current documentation. Laboratory research use only.
Specifications
| Catalog number | 062-10 |
|---|---|
| Product type | Research Peptides |
| Peptide family | Thyrotropin-Releasing Hormone (TRH) |
| Species | Human, Mouse, Rat |
| Unit size | 25 mg |
| Molecular weight | 362.39 Da |
| Purity | ≥ 95% |
| Validation | Exhibits correct molecular weight |
| Appearance | White powder |
| Contents | Each vial contains 25 mg of peptide. Pituitary cocaine- and amphetamine-regulated transcript expression depends on the strain, sex and oestrous cycle in the rat. Kappeler L, Gautron L, Layé S, et al. J Neuroendocrinol. 2006;18(6):426-33. Excitatory effects of thyrotropin-releasing hormone in the thalamus. Broberger C, Mccormick DA. J Neurosci. 2005;25(7):1664-73. Neuropeptide W acts in brain to control prolactin, corticosterone, and growth hormone release. Baker JR, Cardinal K, Bober C, Taylor MM, Samson WK. Endocrinology. 2003;144(7):2816-21. Deficiencies in pro-thyrotropin-releasing hormone processing and abnormalities in thermoregulation in Cpefat/fat mice. Nillni EA, Xie W, Mulcahy L, Sanchez VC, Wetsel WC. J Biol Chem. 2002;277(50):48587-95. Rescue of hypogonadotropic hypogonadism-causing and manufactured GnRH receptor mutants by a specific protein-folding template: misrouted proteins as a novel disease etiology and therapeutic target. Janovick JA, Maya-nunez G, Conn PM. J Clin Endocrinol Metab. 2002;87(7):3255-62. Hypocretin/orexin suppresses corticotroph responsiveness in vitro. Samson WK, Taylor MM. Am J Physiol Regul Integr Comp Physiol. 2001;281(4):R1140-5. |
| Solubility | Soluble in water |
| Intended use | In vitro laboratory research only — not for human or veterinary use, diagnostic or therapeutic purposes |
Sequence
pGlu-His-Pro-NH2
Storage & handling
Up to 6 months in lyophilized form at 0-5°C. For best results, rehydrate just before use. After rehydration, keep solution at +4°C for up to 5 days or freeze at -20°C for up to 3 months. Aliquot before freezing to avoid repeated freeze-thaw cycles.
Confirm handling and preparation requirements against current product documentation and the requirements of your laboratory protocol.
Frequently asked
What is Thyrotropin-Releasing Hormone (TRH) (Human, Rat, Mouse)?
What purity is listed for 062-10?
How should Thyrotropin-Releasing Hormone (TRH) (Human, Rat, Mouse) be stored?
What is the sequence of Thyrotropin-Releasing Hormone (TRH) (Human, Rat, Mouse)?
What is the intended use of 062-10?
This page reproduces an imported research-catalog record. Verify identity, specifications, documentation and suitability before purchase. The item is offered only for laboratory research and is not represented for human or veterinary use.